Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Cytogenetics' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Cytogenetics Technologies, Markets and Companies |
March 2010 | £1455 | 100 % |
|
Strategic Analysis of U.S. Molecular Cytogenetics Markets |
July 2009 | £3965 | 95 % |
|
Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies |
January 2008 | £110 | 94 % |
|
Stakeholder Opinions: Acute Leukemias Persistent unmet needs confer significant commercial opportunity |
April 2006 | £1435 | 20.3 % |
|
Myeloproliferative Disorders: Biology and Management |
October 2007 | £105 | 20.3 % |
|
Bio-Reference Laboratories, Inc. - Financial and Strategic Analysis Review |
June 2009 | £83 | 19.5 % |
|
Molecular Diagnostics A Dynamic and Rapidly Broadening Market Overview |
January 2009 | £2475 | 16.5 % |
|
Multiple Myeloma |
October 2007 | £105 | 15.75 % |
|
HighGrowth Diagnostic Markets |
November 2008 | £2245 | 11.55 % |
|
High-Growth Diagnostic Testing Markets |
November 2008 | £2245 | 11.55 % |
|
Biochips A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 9.8 % |
|
Microscopy Markets |
July 2008 | £2245 | 7.35 % |
|
Molecular Diagnostics Markets |
September 2008 | £2245 | 6.65 % |
|
DNA Probes-Based Diagnostics A Worldwide Market Review |
November 2009 | £1980 | 5.6 % |
|
Drug Discovery Technologies A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 4.2 % |
|
Stakeholder Insight: Chronic Leukemias Is there room left for improvement? |
November 2008 | £5285 | 3.85 % |
|
Molecular Diagnostics Technologies, Markets and Companies |
March 2010 | £3300 | 3.5 % |
|
Animal Biotechnology Technologies, Markets and Companies |
March 2010 | £1650 | 2.8 % |
|
What's Hot in Cancer Drug R&D? |
July 2006 | £295 | 2.8 % |
|
Cell Therapy Technologies, Markets and Companies |
March 2010 | £3300 | 1.4 % |
